Patterns and outcomes of preterm hospital admissions during pregnancy in NSW, 2001-2008

Contains fulltext : 139362.pdf (publisher's version ) (Open Access

Flow Equations without Mean Field Ambiguity

We compare different methods used for non-perturbative calculations in strongly interacting fermionic systems. Mean field theory often shows a basic ambiguity related to the possibility to perform Fierz transformations. The results may then depend strongly on an unphysical parameter which reflects the choice of the mean field, thus limiting the reliability. This ambiguity is absent for Schwinger-Dyson equations or fermionic renormalization group equations. Also renormalization group equations in a partially bosonized setting can overcome the Fierz ambiguity if the truncation is chosen appropriately. This is reassuring since the partially bosonized renormalization group approach constitutes a very promising basis for the explicit treatment of condensates and spontaneous symmetry breaking even for situations where the bosonic correlation length is large.Comment: New version to match the one published in PRD. New title (former title: Solving Mean Field Ambiguity by Flow Equations), added section IX and appendix B. More explanations in the introduction and conclusions. 16 pages, 6 figures and 3 tables uses revtex

Thin-shell wormholes with a generalized Chaplygin gas in Einstein-Born-Infeld theory

We construct spherically symmetric thin-shell wormholes supported by a generalized Chaplygin gas in Born-Infeld electrodynamics coupled to Einstein gravity, and we analyze their stability under radial perturbations. For different values of the Born-Infeld parameter and the charge, we compare the results with those obtained in a previous work for Maxwell electrodynamics. The stability region in the parameter space reduces and then disappears as the value of the Born-Infeld parameter is modified in the sense of a larger departure from Maxwell theory.Comment: 9 pages, 6 figures; v2: improved versio

Blood Eosinophil Count Predicts Treatment Failure and Hospital Readmission for COPD

ACKNOWLEDGEMENTS This study was funded by AstraZeneca. Editorial support was provided by Joanne M. Faysal, MS, and Jennie G. Jacobson, PhD, CMPP, of JK Associates, Inc., and Michael A. Nissen, ELS, of AstraZeneca. This support was funded by AstraZeneca. DATA-SHARING STATEMENT Data underlying the findings described in this manuscript may be requested in accordance with AstraZeneca’s data-sharing policy described at https://astrazenecagroupdt.pharmacm.com/DT/HomePeer reviewedPublisher PD